Pharma Should Be Excluded From Guideline Development – NEJM Editorial
Executive Summary
Standards for the development and adoption of treatment guidelines should be established in light of efforts by industry to manipulate guidelines for commercial purposes, NIH Critical Care Medicine Department senior investigators assert
You may also be interested in...
Attempts To Rein In Drug Reps Should Consider Physician Specialty, Setting
Guidelines directed at the interaction of sales representatives and physicians should be tailored to medical specialties and settings, according to an analysis of a physician survey published in the April 26 New England Journal of Medicine
Attempts To Rein In Drug Reps Should Consider Physician Specialty, Setting
Guidelines directed at the interaction of sales representatives and physicians should be tailored to medical specialties and settings, according to an analysis of a physician survey published in the April 26 New England Journal of Medicine
Industry CME Affiliates Would Be Restricted Under Accrediting Proposal
Continuing medical education providers affiliated with drug manufacturers would be prohibited from conducting CME programs in therapeutic categories where the manufacturer has products under a proposed revision to the Accreditation Council for Continuing Medical Education's standards for providers